Authors:
KIZU R
NAKANISHI T
YAMAMOTO S
HAYAKAWA K
MATSUZAWA A
ERIGUCHI M
TAKEDA Y
AKIYAMA N
KIDANI Y
Citation: R. Kizu et al., SIGNIFICANCE OF WATER SOLUBILITY IN THE GASTROINTESTINAL ABSORPTION OF O)(1R,2R-CYCLOHEXANEDIAMINE)(OXALATO)PLATINUM(IV), AN ORALLY-ACTIVE ANTITUMOR PLATINUM COMPLEX, AND ITS ANALOGS, Anti-cancer drugs, 9(2), 1998, pp. 167-174
Citation: Y. Kidani et R. Kizu, PRECLINICAL STUDY OF ANTITUMOR CL-BRIDGED DINUCLEAR PLATINUM DOCKING COMPOUND [I-OHP-ASTERISK-DDP] OF OXALIPLATIN AND CISPLATIN, Annals of oncology, 9, 1998, pp. 107-107
Citation: R. Kizu et Y. Kidani, PRECLINICAL DEVELOPMENT OF ORALLY ANTITUMOR ACTIVE OXALIPLATIN DERIVATIVE, TRANS-(N-VALERATO)CHLORO(1R, 2R-CYCLOHEXANEDIAMINE) (OXALATO)PLATINUM(IV), Annals of oncology, 9, 1998, pp. 148-148
Authors:
KIZU R
NAKANISHI T
MIYAZAKI M
TASHIRO T
NOJI M
MATSUZAWA A
ERIGUCHI M
TAKEDA Y
AKIYAMA N
KIDANI Y
Citation: R. Kizu et al., AN ORALLY-ACTIVE ANTITUMOR CYCLOHEXANEDIAMINE-PT(IV) COMPLEX - VALERATO)(OXALATO)(1R,2R-CYCLOHEXANEDIAMINE)PT(IV), Anti-cancer drugs, 7(3), 1996, pp. 248-256
Authors:
YAMASHITA T
HIROSE J
NOJI M
SAITO R
TOMIDA H
KIDANI Y
Citation: T. Yamashita et al., CYTOTOXICITY OF PLATINUM(IV) AND PLATINUM(II) COMPLEXES CONTAINING 1R,2R-CYCLOHEXANEDIAMINE AS A LIGAND, Biological & pharmaceutical bulletin, 16(10), 1993, pp. 1014-1018